Skip to Content

Insect Repellent M 3535 use while Breastfeeding

Medically reviewed by Drugs.com. Last updated on Mar 6, 2021.

Insect Repellent M 3535 Levels and Effects while Breastfeeding

Summary of Use during Lactation

No published information is available on the clinical use of insect repellent M 3535 (IR3535) during breastfeeding. However, the Centers for Disease Control and Prevention and U.S. Environmental Protection Agency consider IR3535 to be safe and effective during breastfeeding when used as directed. It should be used by breastfeeding women to avoid exposure to mosquito-borne viruses.[1] Avoid application directly to the nipple and other areas where the infant might directly ingest the product.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Citriodiol, Diethyltoluamide, Icaridin

References

1.
Centers for Disease Control and Prevention. Avoid bug bites. Accessed 6-27/16. http://wwwnc​.cdc.gov​/travel/page/avoid-bug-bites#repellent.

Substance Identification

Substance Name

Insect Repellent M 3535

CAS Registry Number

52304-36-6

Drug Class

  • Breast Feeding
  • Lactation
  • Insect Repellents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.